Location:

Yale Cancer Center researchers have identified a potential therapy that combines two types of molecularly targeted drugs to produce a synergistic effect against head and neck cancer.

Channels: All Journal News, Cancer, Infectious Diseases, Cancer Center Featured Story 2, Local - Connecticut,

Keywords: Head & Neck Cancer, Targeted Therapies, barbara burtness md, Yale Cancer Center, Cancer, HPV, Clinical Care Research

Tony Teixeira from Danbury, Connecticut had minimally invasive robotic surgery to remove a rare heart tumor.

Channels: Cardiovascular Health, Heart Disease, Surgery, Local - Connecticut,

Keywords: Danbury Hospital, WCMG Southbury Cardiology, Dr. Harvey Kramer, Dr. Robert Gallagher, Robotic Cardiac Surgery, Dr. John Pezzimenti, Hodgkin’s Lymphoma, Radiation Therapy, Fairfield County Bank, Cardiovascular, Primary Cardiac Tumor, Heart Tumor, Myxomas, Papillary Fibroelastoma

An 86-year old woman from Danbury, Connecticut had Transcatheter Aortic Valve Replacement (TAVR) to treat severe aortic stenosis. TAVR is a minimally invasive procedure that is a safe alternative for patients who are at intermediate to high risk of complications from open heart surgery.

Channels: Cardiovascular Health, Heart Disease, Local - Connecticut,

Keywords: Danbury, Connecticut, Aortic Stenosis, transcatheter aortic valve replacement, TAVR, Heart Disease, minimally invasive cardiac surgery

Norwalk Hospital same day total joint replacement surgery leaves patient highly active and pain-free

Channels: Arthritis, Surgery, Local - Connecticut,

Keywords: Total Joint Replacement, Total Hip Replacement, Same Day Joint Replacement, Norwalk Hospital, Mark Fletcher, Norwalk, Connecticut, Orthopedic Surgeon, Orthopedic Surgery, Orthopedics, Project Athena

Just as the scientific community was reaching a consensus on the dangerous reality of climate change, the partisan divide on climate change began to widen.

Channels: All Journal News, Climate Science, Environmental Science, Government/Law, Nature, Nature (journal), Local - Connecticut,

Keywords: Climate Change, policy and ethics

In a new study by Yale Cancer Center (YCC), scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology of these new therapeutic targets.

Channels: All Journal News, Cancer, Cell Biology, Immunology, Respiratory Diseases and Disorders, Cell (journal), Cancer Center Featured Story 2, Local - Connecticut,

Keywords: Yale Cancer Center, Cancer, Immunotherapy, PDL1, Lieping Chen, MD

When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. Published today in the Journal of Clinical Oncology (JCO), a study by Yale Cancer Center researchers show a checkpoint inhibitor immunotherapy drug has meaningful benefit for these patients.

Channels: All Journal News, Cancer, Dermatology, Immunology, Cancer Center Featured Story 2, Local - Connecticut, Embargoed Feed - hidden,

Keywords: Immunotherapy, Harriet Kluger, MD, Yale Cancer Center, YALE, Cancer, Brain Metastases, Melanoma, pembrolizumab, PD-1

Branding matters when it comes to choosing a hospital, according to a new novel study by Yale Cancer Center (YCC) researchers published in the journal Annals of Surgical Oncology.

Channels: Cancer, Healthcare, Cancer Center Featured Story 2, Local - Connecticut, All Journal News,

Keywords: Daniel Boffa MD, Cancer, cancer hospital, Yale Cancer Center, Hospital Affiliation, Cancer branding, hospital patient

U.S. and European guidelines on treating Polycythemia Vera (PV), a potentially deadly blood cancer, call for two treatments for patients with high-risk disease: therapeutic phlebotomy and cytoreductive therapy with a drug called hydroxyurea (HU). HU is the most commonly used option, but evidence for HU treatment is limited and both treatments are underused. Now, researchers at Yale Cancer Center have documented reduced risk of death and incidence of blood clots in patients receiving those therapies.

Channels: All Journal News, Blood, Cancer, Cancer Center Featured Story 2, Local - Connecticut,

Keywords: Blood Cancers, Hydroxyurea, Polycythemia Vera, Nikolai A. Podoltsev, M.D., Ph.D., Yale Cancer Center, Cancer, Cancer Research, YALE

Antonio Omuro, M.D., has been appointed the new Chief of Neuro-Oncology and a Leader for the Brain Tumor Program at Yale Cancer Center (YCC) and Smilow Cancer Hospital.

Channels: Cancer, Neuro, Cancer Center Featured Story 2, Local - Connecticut,

Keywords: Yale Cancer Center, Cancer, Brian Cancer, Neuro-oncology, Brain, Antonio Omuro, YALE